PolySciTech's new launch, SpinSwiper, has the potential to speed up microparticle production.

GSK and Save the Children announce criteria for awards that recognize innovation in healthcare for the world&s poorest children.

New toxicology study demonstrates decreased mortality and better tolerability of ADC generated with Smartag platform versus conventional technology.

Covance MarketPlace is designed to enable partnerships between the company';s emerging biotechnology and established pharmaceutical clients.

Cytovance Biologics completes GMP manufacture of ARMO BioSciences& lead product.

Aesica Pharmaceuticals S.r.I. collaborates with QAD to meet China&s Food and Drug Administration's shortened serialization deadline.

Frontage Labs will expand its CMC facility in Exton, PA.

GSK Biologicals receives warning about cGMP compliance issues at its Quebec facility.

Novartis' 13th Annual Malaria Expert Panel focused on access to quality anti-malarials across Africa.

Medicenna Therapeutics selects Kalon Biotherapeutics to manufacture a new brain cancer drug for children and adults.

Recipharm and CTC will offer packages for Phase I studies.

SGS introduces the Cobas 6000 Analyzer System for its France-based laboratory.

Jones Packaging introduces a new solid dose vial line in its Toronto facility.

According to the National Bioscience Report, the US bioscience industry is on course for continued growth.

Abbott will acquire a controlling interest in the Russian pharmaceutical manufacturer Veropharm.

FDA approved Cubist's treatment for skin infections including MRSA.

NIH launched 3D Print Exchange, a public website promoting health and science applications of 3D printing.

Shire reports that AbbVie offer undervalued company.

Dr. Reddy's recalls blood pressure drug due to failed dissolution tests.

FDA cites cGMP violations for API manufacturing at a facility in Tianjin, China.

Big pharma employment dropped by 3% between 2003 and 2013, according to a new jobs report published by EP Vantage.

New services manage clinical or drug manufacturing data in the Verizon cloud or from data centers.

Arecor and the Center for Process Innovation (CPI) Biologics are working on a project to enhance the compatibility of biologics with their containers.

FDA inspection found cGMP violations in the Bangalore, India API manufacturing facility.

Hospira announces a voluntary nationwide recall due to particulates from a glass defect.

The National Institutes of Health and the National Science Foundation set up biomedical innovation and business program.

EDQM details the agency?s accomplishments in 2013.

FDA issues guidance on the use of social media in regards to prescription drugs.